Achille Maris

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $477 billion of assets under management as of December 31, 2025, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 27 offices across four continents. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of Carlyle or any Carlyle-managed fund. Additional notices & disclaimers can be found here: https://www.carlyle.com/notices-and-disclaimers

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $477 billion of assets under management as of December 31, 2025, Carlyle’s purpose is to connect people, ideas, and capital to fuel growth for companies and performance for investors. Carlyle employs more than 2,500 people in 27 offices across four continents. Nothing herein constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of Carlyle or any Carlyle-managed fund. Additional notices & disclaimers can be found here: https://www.carlyle.com/notices-and-disclaimers

Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. ​ The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations. ​ Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster. ​

World leader in cellular stimulation, LPG® Group is a French company set-up in 1986, that designs and commercialises in more than 100 countries non-aggressive and non-invasive treatment solutions for body and face, addressed to healthcare and beauty professionals, as well as the general public. endermologie® treatments are at the heart of the LPG® Group flagship products and in particular the CELLU M6 Alliance®, which reactivates cells through mechanical massage, for medical (scars, lymphatic drainage, oedema, burns etc.) and aesthetic (body remodelling, cellulite, firmness, wrinkles etc.) applications. HUBER 360® EVOLUTION, for its part, offers patients holistic and functional rehabilitation. 🚀20,000 centres equipped in France: physiotherapy practices, beauty institutes, spas. 🚀 28,000 professionals equipped worldwide. 🚀 84,000 people receive endermologie® treatments every day.

Morgan Stanley is a leading global financial services firm providing investment banking, securities, wealth management and investment management services. With a 90-year history, Morgan Stanley today operates in 42 countries serving corporations, governments, institutions, families and individuals. Morgan Stanley is a talent business that demands ongoing investment in our people. Key drivers of our success have been the breadth and tenure of our talent, as well as a unique culture and a set of values that guide our employees. We view Morgan Stanley’s talent and culture as a key competitive advantage enabling the Firm to achieve its potential and drive future success. As an integrated firm with scaled capabilities, we partner with clients at every stage of their financial journey. Our ability to do so is grounded in four pillars that define Morgan Stanley: a clear and consistent strategy to help clients raise, manage and allocate capital; a culture grounded in rigor, humility and partnership; financial strength through capital, earnings power and durability; and growth driven by smart, strategic investment globally. These pillars enable Morgan Stanley to provide trusted advice, operate with resilience across market cycles and deliver long-term value to our clients and shareholders. Social Media Disclosures: mgstn.ly/SocialDisclosure

We are modern value investors focused primarily on transforming services businesses across four sectors in Europe and North America: business services, consumer products and services, financial services and healthcare. We champion founders, entrepreneurs and management teams as they grow and transform their companies, helping them become long-lasting leaders in their industries. Informed by deep industry expertise, we develop theses and then target and invest with intentionality to build portfolios that deliver meaningful customer and shareholder value, and have a positive impact on society. We invest through private equity, structured opportunities, growth & impact, and strategic partnerships, offering flexibility across the capital structure. We take an entrepreneurial, multinational, single-team approach and since inception in 2000, we have invested in more than 100 companies on both sides of the Atlantic. TowerBrook is the first mainstream private equity firm to be certified as a B Corporation, demonstrating leadership in commitment to responsible business practices.